Viatris (XSWX:VTRS) Total Stockholders Equity: CHF11,398 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:VTRS Viatris Inc XSWX:VTRS
63 GF Score
Price CHF13.19
GF Value CHF9.27
! 8 Warning Signs
View Full Analysis

What is Viatris Total Stockholders Equity?

Viatris XSWX:VTRS -0.50% 63 Total Stockholders Equity is CHF11,398 Mil as of Jun. 2026. GuruFocus rates XSWX:VTRS with a GF Score™ of 63/100 and a GF Value™ of CHF9.27. The stock has 8 warning signs investors should review.

Viatris's Total Stockholders Equity for the quarter that ended in Jun. 2026 was CHF11,398 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Viatris's Book Value per Share for the quarter that ended in Jun. 2026 was CHF9.87. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Viatris's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.94.


Viatris  (XSWX:VTRS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Viatris's Book Value per Share for the quarter that ended in Jun. 2026 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Viatris's Debt-to-Equity for the quarter that ended in Jun. 2026 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Viatris Total Stockholders Equity Related Terms


Viatris Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Viatris's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viatris Total Stockholders Equity Chart

Viatris Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18,873.78 19,630.96 17,700.21 16,615.41 11,723.44

Viatris Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,661.93 12,114.73 11,723.44 11,540.01 11,398.34
XSWX:VTRS
63GF Score
Viatris Inc XSWX:VTRS
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of CHF11,398 Mil mean?
Viatris (XSWX:VTRS) has a Total Stockholders Equity of CHF11,398 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Viatris and its competitors.
Is Viatris' Total Stockholders Equity too high?
Viatris' current Total Stockholders Equity is CHF11,398 Mil. Overall, Viatris has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Viatris' Total Stockholders Equity compare to UTHR and NBIX?
Viatris' Total Stockholders Equity of CHF11,398 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Viatris and its competitors. Viatris's current Total Stockholders Equity is CHF11,398 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viatris stock overvalued right now?
Viatris (XSWX:VTRS) has a current Total Stockholders Equity of CHF11,398 Mil. The stock's GF Value™ is CHF9.27, compared to a current price of CHF13.19 — trading 42.3% above its estimated fair value. The current Total Stockholders Equity is CHF11,398 Mil. Viatris' overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Viatris (XSWX:VTRS), the current Total Stockholders Equity is CHF11,398 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viatris (XSWX:VTRS) Overvalued in 2026?

Based on GuruFocus' analysis, Viatris stock appears to be overvalued. The current stock price of CHF13.19 is trading 42.3% above its estimated GF Value™ of CHF9.27.

Key valuation signals for XSWX:VTRS:

  • Total Stockholders Equity: CHF11,398 Mil
  • GF Value™: CHF9.27 vs. price of CHF13.19 (42.3% above fair value)
  • GF Score™: 63/100 with 8 warning signs

No single metric tells the full story. See the XSWX:VTRS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Viatris Business Description

Address 1000 Mylan Boulevard, Canonsburg, PA, USA, 15317
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
63GF Score

Get the complete analysis for XSWX:VTRS

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF13.19
Price
CHF9.27
GF Value